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Epigenetic mechanisms are a class of molecular mechanisms by
which environmental influences, including stress, can interact with
the genome to have long-term consequences for brain plastic-
ity and behavior. As PTSD, by definition, requires exposure to
a traumatic event, and because genes are exquisitely sensitive to
stress and trauma, epigenetic alterations have received attention
as possible contributors to the development and persistence of
PTSD symptoms. In this research topic, empirical support for
the role of epigenetics in PTSD are presented and discussed. The
articles assembled here cover a range of disciplines and experi-
mental approaches in both animal models and humans that link
stress and trauma with epigenetic alterations. Many articles also
offer perspectives on epigenetics and sex differences, diagnosis and
intervention, and future directions to bridge the gap between basic
and clinical work.
Two original research articles provide empirical support for
DNA methylation as a useful biomarker, not only in the detection
and diagnosis of PTSD, but also as a biological measure for pre-
diction of response to treatment, monitoring treatment efficacy,
and prognosis of outcome. Rusiecki et al. (1) explore changes in
DNA methylation of immune-related genes in US military service
members with a PTSD diagnosis, showing differential patterns of
methylation present pre- vs. post-deployment. Yehuda et al. (2)
explore DNA methylation changes in association with changes in
PTSD symptoms and other biological measures (including cor-
tisol levels) in responders and non-responders to psychotherapy
treatment.
Three review articles describe the compelling evidence for
epigenetic alterations, particularly DNA methylation, as a con-
sequence of exposure to stress encountered early in development.
Raabe and Spengler (3) discuss studies showing early-life stress
induced epigenetic alterations of stress genes as an important
pathway in the dysregulation of stress systems in rodents and
patients. Karsten and Baram (4) review the neuroanatomical and
molecular pathways bridging sensory input with gene expression
programing. They especially focus on how either nurturing or
aversive early-life experiences can alter regulation of corticotropin-
releasing hormone gene expression in hypothalamic neurons.
McGowan (5) discusses studies of humans and animal model
analogs that address molecular mechanisms underlying changes
in stress-sensitive physiological systems in response to early-life
trauma, paying particular attention to work on the glucocorti-
coid receptor. In an original research article, Kundakovic et al. (6)
use a rodent model of early-life adversity (separation of infant
mice from the mother) to explore the relationship between stress,
genetic background, and sex in the determination of neurobe-
havioral and epigenetic outcomes. Together, data presented in
these four articles are consistent with the notion that epigenetic
programing early in life confers an enhanced risk on disease devel-
opment upon re-exposure to trauma or stress. Throughout these
articles, sex-specific differences at the epigenetic level are apparent
too, suggesting that epigenetic activity plays an important role in
sex-specificity and susceptibility to stress.
Continuing with a developmental theme, two review articles
provide fascinating perspectives on the relationship between brain
development and plasticity, gene× environment interactions, and
the development of fear systems. Callaghan et al. (7) discuss devel-
opmental transitions in emotional learning and the role early-life
stress has in both prematurely closing critical period plasticity and
accelerating the development of fear learning systems. They also
discuss the provocative idea of reopening critical periods of emo-
tional learning to help treat many anxiety disorders. Nabel and
Morishita (8) consider the potential contributions of “molecular
brakes” identified in visual system development, the major model
of critical period plasticity, to the development of fear system con-
nections. They also discuss epigenetic regulators in the context
of fear system development and their potential as new targets for
therapeutic intervention.
One of the most common problems associated with PTSD is
the persistence of memories of traumatic events. Since decades of
research has shown that changes in gene expression occur when
a memory is formed and stored, investigators have explored the
relationship between DNA methylation and histone modifications
and long-term trajectories in gene regulation associated with fear
memories. These data are extensively described in two review
articles. Maddox et al. (9) review the role of epigenetic mecha-
nisms in animal models of fear learning and memory (Pavlovian
fear conditioning paradigms that produce robust and long-lasting
fear memories in rodents), highlighting epigenetic modulation
of FKBP5 in animal models of PTSD and clinical populations.
Zovkic et al. (10) review literature supporting the involvement
of epigenetics in PTSD, discussing data in the broader context
of epigenetics in stress and fear learning. They also focus on
evidence for epigenetic mechanisms as regulators of predisposi-
tion and resilience to PTSD, and provide a technical overview
of approaches for measuring DNA methylation to encourage
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future investigation of epigenetic mechanisms in animal models
of PTSD.
Finally, though it is clear throughout this topic that DNA
methylation has been the most extensively studied epigenetic alter-
ation in outcomes associated with stress, evidence for histone
modifications and microRNAs (miRNAs) as key epigenetic players
are also emerging. Reul (11) discusses how psychologically stress-
ful events evoke a long-term impact on behavior through changes
in hippocampal function. Data are presented showing that this can
occur through glutamatergic and glucocorticoid-driven changes in
epigenetic regulation of gene transcription (via histone acetylation
for example) within dentate gyrus neurons. In an original research
article, Schmidt et al. (12) explore cortical miRNA expression
profiles in a rodent model of PTSD. miRNAs are a more recent rec-
ognized class of epigenetic modulators of gene activity (or even a
regulator of epigenetic processes), and are small non-coding RNAs
that can regulate gene expression post-transcriptionally. Selective
serotonin reuptake inhibitors (SSRIs) are the only FDA approved
treatment for PTSD, with some evidence that one SSRI, fluoxe-
tine, can ameliorate a subset of PTSD symptoms. These authors
also examine fluoxetine effects on miRNA profiles, which may pro-
vide insight into the mechanisms underlying treatment effects of
antidepressants in PTSD.
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